IRIS
BAIOCCHI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.700
AS - Asia 6.929
EU - Europa 2.974
SA - Sud America 683
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
Totale 41.382
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.579
SG - Singapore 4.577
CN - Cina 929
BR - Brasile 540
RU - Federazione Russa 511
HK - Hong Kong 488
VN - Vietnam 385
DE - Germania 377
IT - Italia 367
UA - Ucraina 362
IE - Irlanda 343
GB - Regno Unito 218
FI - Finlandia 189
SE - Svezia 175
FR - Francia 153
JP - Giappone 115
KR - Corea 104
IN - India 87
PL - Polonia 65
AR - Argentina 56
CA - Canada 53
BD - Bangladesh 45
AT - Austria 42
MX - Messico 42
NL - Olanda 38
ES - Italia 29
ID - Indonesia 28
IQ - Iraq 26
ZA - Sudafrica 26
BE - Belgio 25
EC - Ecuador 20
CO - Colombia 18
TR - Turchia 18
EG - Egitto 15
PK - Pakistan 14
CH - Svizzera 13
VE - Venezuela 13
CL - Cile 12
IL - Israele 12
LT - Lituania 12
MA - Marocco 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 10
EU - Europa 9
PY - Paraguay 9
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CR - Costa Rica 7
JO - Giordania 7
KZ - Kazakistan 7
RO - Romania 7
UY - Uruguay 7
KE - Kenya 6
PE - Perù 6
PH - Filippine 6
TH - Thailandia 6
HN - Honduras 5
IR - Iran 5
MY - Malesia 5
PT - Portogallo 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
LV - Lettonia 4
NO - Norvegia 4
OM - Oman 4
TM - Turkmenistan 4
AL - Albania 3
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
NG - Nigeria 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
DM - Dominica 1
EE - Estonia 1
GT - Guatemala 1
Totale 41.367
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.910
Wilmington 7.524
Houston 6.691
Singapore 1.274
Fairfield 1.024
Ann Arbor 667
Ashburn 667
San Jose 522
Hong Kong 480
Chandler 443
Seattle 442
Cambridge 371
Beijing 366
New York 355
Jacksonville 326
Dublin 311
Medford 249
Santa Clara 192
Dearborn 167
Council Bluffs 151
Los Angeles 151
Ho Chi Minh City 142
The Dalles 141
Rome 135
Lawrence 118
Tokyo 103
Helsinki 101
San Diego 91
Elk Grove Village 86
Hanoi 83
Buffalo 82
Menlo Park 69
Lauterbourg 62
Moscow 62
Zhengzhou 57
São Paulo 56
Mülheim 52
Orem 48
Dallas 39
Frankfurt am Main 38
Milan 38
London 37
Munich 37
Seoul 36
Chicago 32
Nuremberg 32
Warsaw 31
Chennai 25
North Bergen 25
Atlanta 24
Palo Alto 24
Falls Church 23
Redwood City 23
Kraków 22
Montreal 22
Boardman 21
Norwalk 21
Mexico City 20
Shanghai 20
Brussels 19
Denver 19
Manchester 19
Brooklyn 18
Johannesburg 18
Stockholm 18
Vienna 18
Nanjing 17
Redondo Beach 16
San Mateo 16
University Park 16
Colorado Springs 15
Creede 15
Lappeenranta 15
Rio de Janeiro 15
San Francisco 15
Jakarta 14
Mountain View 14
Da Nang 13
Guangzhou 13
Hefei 13
Jersey City 13
Mumbai 13
Paris 13
Toronto 13
Amsterdam 12
Dhaka 12
Miami 12
Phoenix 12
Verona 12
Washington 12
Biên Hòa 11
Columbus 11
Haiphong 11
Saint Petersburg 11
Tashkent 11
Chandigarh 10
Curitiba 10
Kunming 10
Madrid 10
Poplar 10
Totale 32.926
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 607
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. 561
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 553
Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. 551
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 522
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 505
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 497
Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. 495
An unusual endoscopic finding in a patient with melena: Multiple gastric ulcers of regular shape 491
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats 473
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 473
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 470
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 467
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 464
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 462
Leptin attenuates ischemia-reperfusion injury in the rat liver. 457
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 456
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 454
596 453
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 452
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 450
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 447
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 447
Physical examination of the liver: Does it make sense in the third millennium? 447
Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. 446
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 446
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 445
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 442
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. 440
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 440
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 439
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. 438
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 437
Immunosuppression-Free Liver Transplantation 435
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 434
Reduced acute rejection and side effects with neoral in liver transplantation. 434
Sequential changes in serum and biliary bile acids after liver transplantation 433
Liver transplantation for end-stage liver disease related to viral hepatitis 431
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 429
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 428
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 426
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 426
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 424
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 420
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 420
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 419
Regulation of cholangiocyte bile secretion. 418
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 418
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 416
Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores 413
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation 411
Composition and aggregational forms of biliary lipids in human bile after short-term administration of Taurohyodeoxycholic acid 410
Prevention of hepatitis C recurrence after liver transplantation: An update. 410
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 410
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant 406
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 402
Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. 402
Cholangiocarcinoma: Challenges and future needs 400
Liver transplantation for hepatitis C virus end-stage liver cirrhosis as compared with other nonviral indications 398
Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion 397
Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans. 394
Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat 391
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report 390
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. 383
Standard bowel cleansing is highly ineffective in cirrhotic patients undergoing screening colonoscopy 378
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. 374
Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis 373
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 366
An unusual duodenal polyp causing anemia in a liver-transplanted patient 344
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 339
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 339
Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT) 338
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 328
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 327
Neuroendocrine Changes in Cholangiocarcinoma Growth 297
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 296
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 271
Management of cholangiocarcinoma in the third millennium: time to be guided! 266
Feedback signaling between cholangiopathies, ductular reaction, and non-alcoholic fatty liver disease 249
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease 241
Dual role of bile acids on the biliary epithelium: Friend or foe? 233
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 212
Domino liver transplantation: Where are we now? 211
Liver transplantation for hepatocellular carcinoma: Where do we stand? 207
Possible application of melatonin treatment in human diseases of the biliary tract 202
Current Advances in Basic and Translational Research of Cholangiocarcinoma 202
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 198
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 184
Healthy peribiliary glands are necessary for successful liver transplantation 183
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC) 158
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 149
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 149
2016 comprehensive update of the Banff working group on liver allograft pathology: Introduction of antibody-mediated rejection 137
Moving forward in the treatment of cholangiocarcinoma 127
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 118
Organoids and spheroids as novel models for studying cholestatic liver injury and cholangiocarcinoma 112
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 112
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease 111
Totale 37.638
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.717
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 0 0 0 0 0 176 50
2021/20221.543 47 275 100 80 33 223 65 69 106 133 75 337
2022/20231.375 154 111 33 135 126 295 150 91 126 22 100 32
2023/2024537 60 16 61 7 110 108 22 18 11 39 3 82
2024/20255.603 87 752 391 173 34 317 302 140 335 197 1.636 1.239
2025/20266.189 600 250 630 636 574 431 811 783 806 640 28 0
Totale 41.941